Maynard Um
-
-
-
-
-
-
-
Sangamo Therapeutics names interim CFO after financial officer departure
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Sangamo BioSciences (SGMO)
-
-
-
-
-
-
-
Truist Reiterates Buy Rating on Sangamo BioSciences (SGMO), Removes PT
-
-
-
-
-
-
-
Sangamo BioSciences (SGMO) PT Lowered to $2 at Wells Fargo
-
-
-
-
-
-
-
Sangamo Therapeutics (SGMO) Announces Alignment With FDA on Accelerated Approval Pathway for ST-920
-
-
-
396,379 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

